STAT3, a member of the JAK/STAT signaling pathway downstream from IL6/8, is highly expressed in TNBC and connected with tumor initiation, aggressive clinical behavior, unfavorable outcome, and resistance to chemotherapy [152,153]. Here, STAT3 is linked to neoplasm.